FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 38

Author

Admin 425 posts 0 comments

Whitepaper

The Technology Polarizing the Financial Services Industry

Admin Nov 14, 2024
The prevailing sentiment surrounding GAI is one of polarization: the technology is equally viewed as friend and…
Featured News

Ecobank Partners with Nium to Unlock Real-Time Cross-Border Payments Across 35…

Admin Nov 11, 2024
Nium’s real-time payments infrastructure will be integrated into Ecobank’s existing banking operations, empowering…
Featured News

Bank Automation: Transforming the Future of Banking

Admin Nov 8, 2024
In an era defined by technological advancement, the banking sector is undergoing a profound transformation. Bank…
Featured News

FinTech for Startups: How Small Businesses Can Leverage Technology for Big Growth

Admin Nov 7, 2024
In the fast-paced world of startups, businesses are constantly seeking ways to streamline their operations, boost…
Featured News

Asset Management Software – A Guide to Your Investment Journey

Admin Nov 5, 2024
The primary goal of an asset management institution is to maximize profits while eliminating the risks associated…
Featured News

XTransfer Secures 5 Additional US Payment Licenses, Enhancing Global Trade…

Admin Nov 4, 2024
In addition to its existing licenses in Florida, Delaware, and Colorado, XTransfer has now secured a total of…
Featured News

Dragonfly Financial Technologies Adds FedNow Payments to Digital Composable…

Admin Oct 30, 2024
Dragonfly Financial Technologies Corp., a digital banking and treasury management FinTech, today launched FedNow…
Featured News

Tookitaki’s Anti-financial Crime (AFC) Ecosystem helps Banks and Fintech Fight…

Admin Oct 29, 2024
Tookitaki, a global leader in anti-financial crime technology, is reshaping the fight against financial crime…
Featured News

Digital Banking: Embracing the Future of Financial Services

Admin Oct 25, 2024
Embedded finance has swiftly transitioned from a mere buzzword to a pivotal element of the global financial…
Webinar

Embrace Equity – A conversation with women leaders in finance

Admin Oct 24, 2024
Equality is about providing everyone with the same resources and opportunities; equity recognises that individuals…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Future of Finance: Review on the outlook for the UK financial system
    • FinTech and Employee F&F Settlement: How Digital Financial Platforms Are Transforming the Employee Exit Process
    • How AI and Digital Innovation Are Transforming the Future of the FinTech Industry
    • The Power of Ecosystems for Banking
    • The Rise of Fintech: Transforming the Financial Landscape

    ARTICLE

    Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
    2026-08-14T05:00:00Z
    NEW YORK & LYON, France, August, 14, 2026 Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the European Medicines Agency (EMA) has validated the...


    Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering
    2026-08-14T02:23:00Z
    SAN DIEGO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL) (“Zentalis” or the “Company”), a clinical oncology innovator advancing late-stage development of an investigational, potentially first-in-class WEE1 inhibitor,...


    More Cancer Patients Are Opting to Preserve Their Tumors
    2026-08-14T00:28:37Z
    New Tumor-Preservation Service Opens in Arizona, Giving Patients the Opportunity to Preserve Unadulterated Tumor Tissue for Potential Personalized Cancer Immunotherapy


    Nutraville Announces MemoryFuel Launch as Interest Grows Around Creatine Monohydrate, Brain Energy, and Daily Mental Performance
    2026-08-14T00:13:50Z
    Tallmadge, OH, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Nutraville has announced the launch of MemoryFuel, a caffeine-free brain-health powder formulated for adults interested in supporting memory, focus support, mental clarity,...


    BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder
    2026-08-13T21:42:56Z
    PALO ALTO, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, announced today the...


    BioSyent Schedules Q2 and H1 2026 Earnings Release for August 20, 2026
    2026-08-13T21:30:00Z
    MISSISSAUGA, Ontario, Aug. 13, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its consolidated financial results for the three and six months ended...


    Satellos Reports Second Quarter 2026 Financial Results and Highlights Company Progress
    2026-08-13T21:02:00Z
    TORONTO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative muscle diseases, today announced financial...


    NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026
    2026-08-13T21:00:42Z
    ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and...


    Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    2026-08-13T21:00:00Z
    DALLAS, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a biotechnology company focused on identifying and advancing innovative therapeutics, today reported its second quarter 2026 financial...


    Maze Therapeutics Announces Appointments to Its Board of Directors
    2026-08-13T20:42:25Z
    Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., join Maze’s Board of Directors, adding to the Company’s deep bench of clinical and industry experience


    Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
    2026-08-13T20:30:00Z
    Received positive pre-IND feedback from the U.S. FDA for CLD-401, indicating agreement on the current development strategy toward a first-in-human study targeting first patient dosing in Q1 2027


    Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update
    2026-08-13T20:25:51Z
    Executed a development collaboration with Senlang Biotechnology to advance certain in vivo CAR-T product candidates, including TPST-4003, a CD7-targeted next-generation in vivo CAR-T, with first patient dosing anticipated in the...


    Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates
    2026-08-13T20:20:00Z
    -- Topline data from Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expected in 2H26 ---- Olvi-Vec systemic development programs continue to advance, with additional dose-escalation updates anticipated in 2026...


    Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results
    2026-08-13T20:15:00Z
    TORONTO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three...


    Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform
    2026-08-13T20:15:00Z
    AKTX-101 advancing through IND-enabling development activities toward planned initiation of Phase 1 clinical trial in mid-2027


    Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process
    2026-08-13T20:15:00Z
    Late-breaking Phase 2 CAD-1005 data presented at ISTH support a late-stage portfolio organized around preoperative safety, orphan regulatory acceleration, and postoperative shielding


    Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey
    2026-08-13T20:15:00Z
    A patient-centered initiative focused on education, connection, and support


    Serina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
    2026-08-13T20:15:00Z
    HUNTSVILLE, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today...


    Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results
    2026-08-13T20:10:00Z
    Independent Blinded Survey of 50 Plastic Surgeons Validates Demand; NXT-41 and NXT-41x Remain On-Track


    Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update
    2026-08-13T20:06:35Z
    MINNEAPOLIS, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tumor indications, today...


    Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights
    2026-08-13T20:05:00Z
    NEW HAVEN, Conn., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced financial results for the second quarter ended June 30, 2026, and recent business highlights.


    Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
    2026-08-13T20:05:00Z
    RADNOR, Pa., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions...


    Glass House Brands Reports Second Quarter 2026 Financial Results
    2026-08-13T20:05:00Z
    LONG BEACH, Calif. and TORONTO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (NYSE: GLAS), one of the fastest-growing cannabis...


    Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    2026-08-13T20:05:00Z
    BEDFORD, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that...


    Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
    2026-08-13T20:05:00Z
    Successful End-of-Phase 2 meeting with FDA supports advancement of tegoprubart into a global Phase 3 kidney transplantation trial, on track to initiate in late 2026


    MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position
    2026-08-13T20:05:00Z
    ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today reported financial...


    ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026
    2026-08-13T20:05:00Z
    PORTLAND, Maine, Aug. 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets products to improve calf...


    CapsoVision Reports Second Quarter 2026 Financial Results
    2026-08-13T20:05:00Z
    SARATOGA, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial results and...


    Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update
    2026-08-13T20:05:00Z
    Company updates anticipated commercial launch of Proteus to Q2 2027, cost-reduction actions expected to extend cash runway into Q4 2028 and highlights estimated new market opportunities for protein sequencing


    4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
    2026-08-13T20:05:00Z
    EMERYVILLE, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.